Antibody-Based Therapies in Multiple Myeloma
Bone Marrow Research · 2011
DOI: 10.1155/2011/924058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone Marrow Research, 2011. Verfasst von Yu-Tzu Tai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The unmet need for improved multiple myeloma (MM) therapy has stimulated clinical development of monoclonal antibodies (mAbs) targeting either MM cells or cells of the bone marrow (BM) microenvironment. In contrast to small-molecule inhibitors, therapeutic mAbs present the potential to specifically target tumor cells and directly induce an immune response to lyse tumor cells. Unique immune-effector mechanisms are only triggered by therapeutic mAbs but not by small molecule targeting agents. Although therapeutic murine mAbs or chimeric mAbs can cause immunogenicity, the advancement of genetic recombination for humanizing rodent mAbs has allowed large-scale production and designation of mAbs with better affinities, efficient selection, decreasing immunogenicity, and improved effector functions. These advancements of antibody engineering technologies have largely overcome the critical obstacle of antibody immunogenicity and enabled the development and subsequent Food and Drug Administration (FDA) approval of therapeutic Abs for cancer and other diseases.
Autor:innen und Institutionen
- Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Zitieren
APA
Tai, Y. T., & Anderson, K. C. (2011). Antibody-Based Therapies in Multiple Myeloma. Bone Marrow Research. https://doi.org/10.1155/2011/924058
Vancouver
Tai YT, Anderson KC. Antibody-Based Therapies in Multiple Myeloma. Bone Marrow Research. 2011. doi:10.1155/2011/924058
BibTeX
@article{Tai2011,
author = {Tai, Yu-Tzu and Anderson, Kenneth C},
title = {Antibody-Based Therapies in Multiple Myeloma},
journal = {Bone Marrow Research},
year = {2011},
doi = {10.1155/2011/924058}
}
EUVIMED